The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Predisposition of COVID-19 patients to secondary infections: set in stone or subject to change?
Abstract
Purpose of review: There likely are several predisposing factors to secondary infections in patients with Coronavirus disease 2019 (COVID-19), some of which may be preventable. The aim of this review is to explore the literature, summarize potential predisposing factors to secondary infections and their incidence. It also summarizes a variety of healthcare scenarios in which different kinds of secondary infections occur. Recent findings: Apart from immune dysregulation, severe resource limitations in healthcare settings have made COVID-19 units conducive to a variety of secondary infections. Long-term effect of excess antibiotic use in COVID-19 patients is yet to be studied. Very few studies have assessed secondary infections as the primary outcome measure making it difficult to know the true incidence. Mortality attributable to secondary infections in COVID-19 patients is also unclear. Summary: Incidence of secondary infections in COVID-19 patients is likely higher than what is reported in the literature. Well designed studies are needed to understand the incidence and impact of secondary infections in this patient population. Many of these may be preventable especially now, as personal protective equipment and other healthcare resources are recovering. Infection prevention and control (IPC) and antimicrobial stewardship programmes (ASP) must reassess current situation to correct any breaches that could potentially cause more harm in these already vulnerable patients as we brace for a future surge with another pandemic wave.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Changes to healthcare systems during the COVID-19 pandemic (eg, lapses in infection control practices, increased antimicrobial prescribing) and the high acuity of care required for patients with COVID-19 infections (eg, invasive devices, long lengths of stay), likely contributed to the increased risk of IC among patients with COVID-19.41,42”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [42]
Citations
Cites
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263
Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period
Kissler, S. M., Tedijanto, C., Goldstein, E., Grad, Y. H., & Lipsitch, M. (2020) · Science · doi:10.1126/science.abb5793 · Cited by 2,611
Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)
Diao, B., Wang, C., Tan, Y., Chen, X., Liu, Y., Ning, L., Chen, L., Li, M., Liu, Y., Wang, G., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00827 · Cited by 2,475
Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure
Giamarellos-Bourboulis, E. J., Netea, M. G., Rovina, N., Akinosoglou, K., Antoniadou, A., Antonakos, N., Damoraki, G., Gkavogianni, T., Adami, M.-E., Katsaounou, P., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.04.009 · Cited by 2,045 · cited 1×
“SARS-CoV-2 infection leads to sustained production of tumour necrosis factor- a (TNF- a) and inter-leukin-6 (IL-6) resulting in hyper-inflammation [11].”
BackgroundInterleukin-6 receptor antagonists in critically ill patients with Covid-19.
The REMAP-CAP Investigators (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2100433 · Cited by 1,962
Rawson, T. M., Moore, L. S. P., Zhu, N., Ranganathan, N., Skolimowska, K., Gilchrist, M., Satta, G., Cooke, G., & Holmes, A. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa530 · Cited by 1,662
Cheung, K. S., Hung, I. F. N., Chan, P. P. Y., Lung, K. C., Tso, E., Liu, R., Ng, Y. Y., Chu, M. Y., Chung, T. W. H., Tam, A. R., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.03.065 · Cited by 1,631 · cited 1×
“Bacterial translocation may be an early event related to intestinal damage due to tissue infection, systemic inflammation-induced dysfunction and IL-6 mediated diffuse vascular damage [45] and due to ischemic enteritis and mesenteric infarctions [46,47].”
BackgroundMorens, D. M., Taubenberger, J. K., & Fauci, A. S. (2008) · The Journal of Infectious Diseases · doi:10.1086/591708 · Cited by 1,625 · cited 2×
“1918–1919 influenza pandemic resulted directly from secondary bacterial pneumonia [1,2].”
BackgroundCo-infections in people with COVID-19: a systematic review and meta-analysis.
Lansbury, L., Lim, B., Baskaran, V., & Lim, W. S. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.05.046 · Cited by 1,619
Langford, B. J., So, M., Raybardhan, S., Leung, V., Westwood, D., MacFadden, D. R., Soucy, J.-P. R., & Daneman, N. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.07.016 · Cited by 1,569
Research works printed but not linked: 7
- MacCallum, 1921, Pathological anatomy of pneumonia associated with influenza; 23 plates, Johns Hopkins Hosp Rep, 20, 149
- Arteaga-Livias, 2021, A multidrug-resistant Klebsiella pneumoniae outbreak in a Peruvian hospital: another threat from the COVID-19 pandemic, Infect Control Hosp Epidemiol, 1-2
- Bhatt, 2020, Risk factors and outcomes of hospitalized patients with severe COVID-19 and secondary bloodstream infections: a multicenter, case-control study, Clin Infect Dis, ciaa1748
- Vaughn, 2020, Empiric antibacterial therapy and community-onset bacterial co-infection in patients hospitalized with COVID-19: a multi-hospital cohort study, Clin Infect Dis, ciaa1239
- Lehmann, 2020, Community acquired co-infection in COVID-19: a retrospective observational experience, Clin Infect Dis, ciaa902
- Mastrangelo, 2020, Candidemia in COVID-19 patients: incidence and characteristics in a prospective cohort compared to historical non-COVID-19 controls, Clin Infect Dis, ciaa1594
- White, 2020, Candidaemia in COVID-19, a link to disease pathology or increased clinical pressures?, Clin Infect Dis, ciaa1597
Cited by
Epidemiology of Invasive Candidiasis
Bays, D., Jenkins, E., Lyman, M., Chiller, T., Strong, N., Ostrosky-Zeichner, L., Hoenigl, M., Pappas, P., & Thompson, G. (2024) · Clinical Epidemiology · doi:10.2147/clep.s459600 · Cited by 109
Metadata
- Authors
- Sopirala, M. M.
- Affiliations
- VA North Texas Health Care System (US)
- Corresponding author
- Sopirala, Madhuri M.
- ORCID
- Sopirala, Madhuri M.
- Venue
- Current Opinion in Infectious Diseases
- Published
- 2021-05-25
- Volume
- 34
- Issue
- 4
- Pages
- 357-364
- ISSN
- 0951-7375 (ISSN-L)
- 1473-6527
- OpenAlex
- W3165260612
- Semantic Scholar
- 58f88870eca3beb40b59fa4e6e0cfcc27c4ce17b
- Cited by
- 8
- References
- 75
- Citations by year
- 2024: 2 · 2023: 1 · 2022: 5
- FWCI
- 0.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Opinion in Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
- Health Sciences › Medicine › Oncology › COVID-19 and healthcare impacts
- Keywords
- COVID-19 pandemic, secondary infection, nosocomial infections, SARS-CoV-2, immune dysregulation, healthcare resource constraints, antibiotic use, infection control, antimicrobial stewardship, personal protective equipment
- MeSH terms
- Clinical Decision-Making, Antimicrobial Stewardship, COVID-19, SARS-CoV-2, Disease Susceptibility, Health Personnel, Humans, Mortality, Incidence, Immunocompromised Host, Disease Management, Standard of Care, Coinfection
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Predisposition of COVID-19 patients to secondary infections: set in stone or subject to change? https://app.cochat.ai/papers/10.1097/qco.0000000000000736
- The paper
- Sopirala, M. M. (2021). Predisposition of COVID-19 patients to secondary infections: set in stone or subject to change? Current Opinion in Infectious Diseases. https://doi.org/10.1097/qco.0000000000000736
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.